共 50 条
- [1] Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort studyBMC CANCER, 2021, 21 (01)Zok, JolantaBienkowski, MichalRadecka, BarbaraKorniluk, JanAdamowicz, KrzysztofDuchnowska, Renata
- [2] Cumulative dose of oxaliplatin in adjuvant therapy for stage III colon cancer patients: Impact on survivalJOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Zok, JolantaRadecka, BarbaraAdamowicz, KrzysztofJan, KornilukDuchnowska, RenataWysokinska, Ewa Maria
- [3] Impact of Relative Dose Intensity of FOLFOX Adjuvant Chemotherapy on Risk of Death Among Stage III Colon Cancer PatientsCLINICAL COLORECTAL CANCER, 2022, 21 (02) : E62 - E75Zhou, MeijiaoThompson, Trevor D.Lin, Hui-YiChen, Vivien W.Karlitz, Jordan J.Fontham, Elizabeth T. H.Theall, Katherine P.Zhang, LuHsieh, Mei-ChinPollack, Lori A.Wu, Xiao-Cheng
- [4] Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veteransBMC Cancer, 15Sherrie L AspinallChester B GoodXinhua ZhaoFrancesca E CunninghamBernadette B HeronMark GeraciVida PasseroRoslyn A StoneKenneth J SmithRenee RogersJenna ShieldsMegan SartoreD Patrick BoyleSherry GibertiJohn SzymanskiDoug SmithAllen HaJolynn SessionsShawn DepcinskiShane FishcoIrvin MolinaTanja LepirCarmela JeanLymaris Cruz-DiazJessica MottaRebeca Calderon-VargasJanelle MalandSean KeefeMarshall TagueAlice LeoneBrian GlovackBlair KaplanSean CosgriffLindsay KasterIvy Tonnu-MiharaKimmai NguyenJenna CarmichaelLinda CliffordKan LuGurkamal Chatta
- [5] Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veteransBMC CANCER, 2015, 15Aspinall, Sherrie L.Good, Chester B.Zhao, XinhuaCunningham, Francesca E.Heron, Bernadette B.Geraci, MarkPassero, VidaStone, Roslyn A.Smith, Kenneth J.Rogers, ReneeShields, JennaSartore, MeganBoyle, D. PatrickGiberti, SherrySzymanski, JohnSmith, DougHa, AllenSessions, JolynnDepcinski, ShawnFishco, ShaneMolina, IrvinLepir, TanjaJean, CarmelaCruz-Diaz, LymarisMotta, JessicaCalderon-Vargas, RebecaMaland, JanelleKeefe, SeanTague, MarshallLeone, AliceGlovack, BrianKaplan, BlairCosgriff, SeanKaster, LindsayTonnu-Mihara, IvyNguyen, KimmaiCarmichael, JennaClifford, LindaLu, KanChatta, Gurkamal
- [6] Efficacy and Safety of Capecitabine and Oxaliplatin (CapOX) as an Adjuvant Therapy in Japanese for Stage II/III Colon Cancer in a Group at High Risk of Recurrence in Retrospective StudyONCOLOGY RESEARCH, 2015, 22 (5-6) : 325 - 331Osawa, HiroshiHanda, NaokoMinakata, Kunihiko
- [7] Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patientsTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13Boakye, DanielJansen, LinaHalama, NielsChang-Claude, JennyHoffmeister, MichaelBrenner, Hermann
- [8] Pilot study of the combination of capecitabine plus oxaliplatin as adjuvant therapy for patients with stage III and high risk stage II colon cancerJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Olier, C.Reyna, C.Aramendia, J. M.Rodriguez, J.Viudez, A.Chopitea, A.Garcia-Foncillas, J.
- [9] Prognostic impact of the number of administrations of oxaliplatin in the adjuvant treatment of stage III colon cancerANNALS OF ONCOLOGY, 2020, 31 : S102 - S102Reis, J.Costa, I.Valente, A.Costa, M.Fernandes, C.Tavares, N.Sarmento, C.Caeiro, C.Barbosa, M.